Dublin, Ireland

John Devane

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Mind of John Devane

Introduction

John Devane, an accomplished inventor based in Dublin, Ireland, has made significant contributions to the field of pharmaceutical formulations. With a remarkable portfolio of 11 patents, his work centers on the innovative development of baclofen formulations that demonstrate reduced variability in patient exposure to metabolites.

Latest Patents

Among his latest patents, two noteworthy innovations stand out:

1. **Baclofen Formulations and Methods of Minimizing Patient Exposure to Metabolite Variations** - This patent focuses on developing baclofen formulations that not only minimize variability between doses but also reduce variation in patient exposure to baclofen metabolites. These formulations aim for bioequivalence regarding the baclofen versus M1 metabolite ratios found in baclofen tablets.

2. **Compositions and Methods of Administering Baclofen** - This invention describes injectable baclofen formulations and methods that are bioequivalent in terms of plasma baclofen exposure when compared to oral dosage forms. However, these injectable formulations exhibit reduced exposure ratios of baclofen to the M1 metabolite, providing a significant advancement in patient care.

Career Highlights

Throughout his career, John has worked with esteemed companies in the pharmaceutical industry. His experience includes roles at Amneal Pharmaceuticals LLC and Saol International Development Ltd. These positions allowed him to collaborate on innovative drug development projects aimed at enhancing patient outcomes through improved medication options.

Collaborations

John's collaborative efforts have been instrumental in the success of his projects. Notably, he has worked alongside talented professionals such as David Penake and Sharon Hamm, both of whom have contributed invaluable expertise throughout their joint endeavors in the field of pharmaceutical research and development.

Conclusion

John Devane's innovative spirit and commitment to advancing pharmaceutical science have resulted in numerous patents that demonstrate his dedication to improving patient care. His work continues to influence the industry as he strives to create formulations that effectively address the complexities of drug metabolism and dosage variability.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…